LASONIL

LASONIL PAIN RELIEF 10% GEL 1 TUBE OF 120 G

LASONIL PAIN RELIEF 10% GEL 1 TUBE OF 120 G

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Name
Lasonil 10% pain reliever gel
Ibuprofen lysine salt


What is it and what is it for?
This medicine contains ibuprofen lysine salt, which belongs to a group of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs), which work to relieve pain and reduce symptoms related to inflammation.

Lasonil pain reliever is used for the local treatment of bruises, sprains, myalgia (muscle pain), muscle strains, and stiff neck.

Contact your doctor if you do not feel better or if your symptoms worsen.


What you need to know before taking the medicine
Do not use Lasonil pain reliever
- if you are allergic to ibuprofen or any of the other ingredients of this medicine (listed in section 6).
- if you are allergic to other analgesics (painkillers), antipyretics (feverkillers), non-steroidal anti-inflammatory drugs (NSAIDs) that have previously caused asthma, rhinitis, urticaria or other allergic reactions.
- if you are in the last 3 months of pregnancy (see " Pregnancy, breastfeeding and fertility ").
- if you are breastfeeding (see " Pregnancy, breastfeeding and fertility ").
- if you are under 14 years of age (see " Children and adolescents ").
- if you use other NSAIDs (see " Other medicines and Lasonil pain reliever ").


Warnings and precautions
Talk to your doctor or pharmacist before using Lasonil pain reliever:
- if you suffer or have ever suffered from asthma, allergic rhinitis, urticaria or other allergic reactions after using acetylsalicylic acid or other similar anti-inflammatories.
- if you are taking anticoagulant medicines (drugs used to thin the blood) such as warfarin at the same time (see "Other medicines and Lasonil pain reliever")

It is advisable to avoid applying Lasonil pain reliever on open wounds or skin lesions.

Skin reactions

The use of Lasonil pain reliever, especially if prolonged, can give rise to local sensitization phenomena: at the first appearance of a skin rash (eruption), lesions of the mucosa or any other sign of hypersensitivity, discontinue treatment and consult your doctor who will be able to adopt appropriate therapeutic measures.

To avoid more serious hypersensitivity or photosensitivity phenomena (skin erythema after applying the product and subsequent exposure to light, whether solar or UV), do not expose yourself to direct sunlight, including solarium, during treatment and for the two weeks following (see section 4. Possible side effects).

Serious skin reactions, including exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP), have been reported in association with treatment with Lasonil painkiller. Stop using Lasonil painkiller and contact your doctor immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.

Children and adolescents
The use of the medicine is reserved only for patients over 14 years of age.


Possible side effects
Stop using Lasonil Antidolore and consult your doctor immediately if you notice any of the following symptoms:

- flat, reddish, target-shaped or circular spots on the trunk, often with central blisters, peeling skin, and ulcers of the mouth, throat, nose, genitals, and eyes. These severe rashes may be preceded by fever and flu-like symptoms [exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis].
- widespread skin rash, high body temperature and swollen lymph nodes (DRESS syndrome).
- widespread, red, scaly rash with bumps under the skin and blisters, accompanied by fever. Symptoms usually appear at the start of treatment (acute generalized exanthematous pustulosis).

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms.

Skin reactions with erythema, itching, irritation, sensation of heat or burning and contact dermatitis have been reported with some nonsteroidal anti-inflammatory drugs applied to the skin.

The skin becomes sensitive to light. Photosensitivity reactions (skin rash after applying the product and subsequent exposure to light, whether solar or UV) are possible. Side effects reported with an unknown frequency (i.e., the frequency cannot be estimated from the available data). See also section 2.

Following the instructions in the package leaflet reduces the risk of side effects.

Reporting of side effects
If you experience any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse .
By reporting side effects you can help provide more information on the safety of this medicine.

LASONIL

LASONIL PAIN RELIEF 10% GEL 1 TUBE OF 120 G

LASONIL PAIN RELIEF 10% GEL 1 TUBE OF 120 G

MINSAN code: 042154029
Previous price: €14,50
Regular price €14,50
Regular price €15,60 Sale price €14,50
-7% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.